The effect of DMSO and sodium butyrate on the production of recombinant hepatitis A virus (HAV) capsid protein VP1 was evaluated and optimized in the culture of stably transfected Drosophila melanogaster S2 cells using culture plates and spinner flasks. The effect of DMSO and sodium butyrate was also evaluated to improve the recombinant VP1 production in stably transfected Drosophila S2 cells. A production level of 0.88 mg of recombinant VP1/liter was obtained in the culture-plate culture of stably transfected S2 cells at 6 days after induction with 0.5 mM CuSO 4 . The supplements of 2% DMSO and 10 mM sodium butyrate at 4 days post-inoculation increased recombinant VP1 accumulation by 141 and 104%, respectively, resulting in 2.17 and 1.7 mg/liter of recombinant VP1 production. In spinner flasks, recombinant VP1 production reached maximum level at 9 days after induction with 0.5 mM CuSO 4 , with approximately 4.96 mg/liter of recombinant VP1 production level. When 2% DMSO or 10 mM sodium butyrate was added at 5 days post-inoculation, the recombinant VP1 production was increased to 8.35 and 5.85 mg/liter, respectively. However, the synergistic effects of DMSO and sodium butyrate were not observed. These results indicate that DMSO and/or sodium butyrate can be successfully used to improve the recombinant HAV VP1 production in culture plates and spinner flasks.
INTRODUCTION
production from Drosophila S2 cell systems has not yet been fully optimized. In this study, to improve recombinant VP1 production from stably transfected Drosophila S2 cells, we optimized the production of recombinant VP1 in culture plates and spinner flasks and investigated the effect of dimethylsulfoxide (DMSO) and sodium butyrate on recombinant VP1 production. 
MATERIALS AND METHODS

Cell
SDS-PAGE and Western blot analysis
Protein samples were separated by electrophoresis on 8%
polyacrylamide-SDS gels (11) , and analyzed using Western 
RESULTS AND DISCUSSION
In our previous work, we generated stably transfected Drosophila S2 cells expressing recombinant HAV VP1
protein (10) . Recombinant VP1 was secreted into a medium with a molecular size of 42~49 kDa, due to glycosylation.
The secreted recombinant VP1 (VP1 in medium fraction) was approximately 90% of the total VP1 production.
Dimethylsulfoxide (DMSO) has been known to be an effective permeabilizing agent that helps the release of intracellular products from plant cells (12) as well as a stabilizing agent for proteins (13) . DMSO treatment can have a stimulatory effect on protein expression in animal cells (14, 15) while sodium butyrate has been known to increase recombinant protein expression in animal cells (16, 17) . Although the mechanism of DMSO and sodium butyrate-mediated induction of protein expression is not clearly defined, DMSO is suggested to improve recombinant protein production by increasing the stability of the recombinant protein or by increasing transcription efficiency a The content of recombinant VP1 obtained from medium fraction of non-treated cultures was represented as 100. The other runs were expressed as relative contents with respect to this value. b ND: non-detected two and four days post-inoculation so that the stably transfected S2 cells were incubated with DMSO or sodium butyrate for six, four and two days, respectively. The DMSO supplement inhibited cell growth but increased recombinant VP1 production in medium fractions (Table 1) . Recombinant VP1 accumulation reached maximum level with a supplement of 2% DMSO at four days post-inoculation. At this peak, recombinant VP1 production was 141% higher than control, which is between the 80% increase reported for recombinant rotavirus VP7 production in stably transfected D. melanogaster S2 cells (21) and the 170% increase for recombinant cyclooxygenase 2 (18) . The sodium butyrate supplement also inhibited cell growth but increased VP1 production ( Table 2) . Maximum VP1 production of 104% higher as compared to the control, which is higher than the 60 and 86% increase reported for recombinant rotavirus VP7 and cyclooxygenase 2 production in stably transfected S2 cells (18, 21) , was reached at four days post-inoculation with the 10 mM sodium butyrate supplement.
The synergy of DMSO and sodium butyrate on recombinant VP1 production was also investigated (Fig. 1) .
Both DMSO (2%) and sodium butyrate (10 mM) were added to the cultures at four days post-inoculation at an initial cell density of 3 × 10 6 cells/ml. As a control, either DMSO (2%) or sodium butyrate (10 mM) was added at four days post-inoculation to cultures under the same condition. Statistically significant differences between treatment and control groups were determined using Student's t test (** p < 0.01).
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The recombinant VP1 productions were determined after six days after incubations. A production level of 0.88 mg of recombinant VP1/liter was obtained in culture-plate culture of stably transfected S2 cells six days after induction with 0.5 mM CuSO 4 , based on Western blot analysis using recombinant VP1 purified from stably transfected S2 cells (Fig. 1A and B) , which is less than the maximum production level of 6.24 mg of recombinant VP1/liter obtained in . Therefore, decrease in recombinant VP1 production in culture plates was probably due to the differences in culture medium and initial cell density. DMSO and sodium butyrate increased the recombinant VP1 production to 2.17 and 1.7 mg/liter, respectively ( Fig. 1A and B) . In comparisons to DMSO only, supplementation with both DMSO and sodium butyrate resulted in lower recombinant VP1 production; there was no synergistic interaction between DMSO and sodium butyrate.
The stably transfected S2 cells were also cultured in spinner flasks to increase the recombinant VP1 production.
The S2 cells of initial density of 3 × 10 6 cells/ml were inoculated in 100 ml spinner flasks containing 50 ml culture medium and recombinant VP1 production was induced by the addition of 0.5 mM CuSO 4 at zero day. DMSO or sodium butyrate was added at five days after CuSO 4 induction; the addition of DMSO and sodium butyrate resulted in slight inhibition of cell growth (Fig. 2) , whereas recombinant VP1 production was increased by DMSO and sodium butyrate (Table 3) , reaching the maximum at nine days after CuSO 4 induction. The presence of 2% DMSO and 10 mM sodium butyrate separately increased the recombinant VP1 production by 63.3 and 13.2%, respectively.
Moreover, recombinant VP1 production was lower when supplemented with both 2% DMSO and 10 mM sodium butyrate than with 2% DMSO only, suggesting no synergistic interaction between DMSO and sodium butyrate. The production level of recombinant VP1 in spinner flasks was about 4.96 mg/liter at 9 days after CuSO 4 induction, based on Western blot analysis using recombinant VP1 purified from stably transfected S2 cells (Fig. 3) . The DMSO and sodium butyrate treatments increased the recombinant VP1 production levels to 8.35 and 5.85 mg/liter, respectively.
These levels are much higher than obtained in culture plates.
A level of 8.35 mg/liter is also better than our previously reported expression level (6.24 mg/liter) for Drosophila S2 cells (10).
In conclusion, the effect of DMSO and sodium butyrate was evaluated to improve the recombinant VP1 production in stably transfected Drosophila S2 cells. The supplementation of DMSO and sodium butyrate dramatically increased the recombinant VP1 production in culture plates and spinner flasks.
